bioXXmed Μέρισμα 2024

Τι κάνει η bioXXmed;

Το CytoTools AG is a German biotechnology company based in Darmstadt. It was founded in 2000 and has been listed on the Frankfurt Stock Exchange since 2006. The company focuses on the development of innovative therapies for diseases that have been difficult or impossible to treat so far. CytoTools relies on the use of active substances developed based on endogenous (body's own) molecules. A particular focus is on the research and development of active substances for the treatment of diseases based on inflammatory processes. CytoTools works closely with international research and development partners in this area. CytoTools' business model is based on the development and marketing of products based on innovative technologies and active substances. As a biotechnology company, it specializes in the development of patent-protected products and pursues a scalable business model. The company is divided into various divisions. In the "Pharmaceuticals" division, CytoTools develops innovative active substances and drugs for the treatment of diseases such as inflammatory diseases, cancer, or diabetes. An example of this is the active substance DermaPro, which can be used to treat chronic wounds. In the "Medical Devices" division, CytoTools develops medical devices for the diagnosis and therapy of diseases. An example of this is the CytoSorb system, which is used for extracorporeal blood detoxification and thus supports the treatment of severe infectious and inflammatory diseases. The third division of CytoTools is "Diagnostics". Here, the company develops innovative diagnostic tools for early detection of diseases. An example of this is the biomarker-based rapid test DermaPro Inflammation Score, which allows for a quick and reliable assessment of the inflammatory state of wounds. CytoTools has a strong network of partners and cooperation partners. The most important partners include institutions such as Kiel University, Flensburg University, or the Institute of Molecular Biotechnology in Jena. In addition, CytoTools works closely with international partners from the pharmaceutical industry. Overall, CytoTools is an innovative and rapidly growing biotechnology company specializing in the development of patent-protected products and technologies for the treatment of severe and previously incurable diseases. With its strong network of research and development partners and a wide range of products, the company is well-positioned to continue growing and develop new therapy concepts in the future. bioXXmed είναι μία από τις πιο δημοφιλείς εταιρείες στο Eulerpool.com.